Serial Number 88171017
Registration 5922425
700

Registration Progress

Application Filed
Oct 26, 2018
Under Examination
Apr 30, 2019
Approved for Publication
Mar 5, 2019
Published for Opposition
Mar 5, 2019
Registered
Nov 26, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20191126) (Grace Period Filing)
Due: May 26, 2026 Grace Period - 138 days
Original deadline was Nov 26, 2025 (overdue)

Trademark Image

Basic Information

Serial Number
88171017
Registration Number
5922425
Filing Date
October 26, 2018
Registration Date
November 26, 2019
Published for Opposition
March 5, 2019
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 26, 2019
Registration
Registered
Classes
005

Rights Holder

AbbVie Biotechnology Ltd

03
Address
Thistle House, 4 Burnaby Street Hamilto
Pembroke HM11
BM

Ownership History

AbbVie Biotechnology Ltd

Original Applicant
03
Hamilton BM

AbbVie Biotechnology Ltd

Owner at Publication
03
Hamilton BM

AbbVie Biotechnology Ltd

Original Registrant
03
Pembroke BM

Legal Representation

Attorney
Sonali S. Srivastava

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20191126)
Due Date
November 26, 2025
Grace Period Ends
May 26, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

18 events
Date Code Type Description Documents
Nov 17, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Nov 26, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Nov 26, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 22, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 21, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 21, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 29, 2019 IUAF S USE AMENDMENT FILED Loading...
Sep 21, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 29, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 30, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 13, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 24, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2018 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 9, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 30, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Anywhere: Aug 16, 2019
First Use in Commerce: Aug 16, 2019

Additional Information

Design Mark
The mark consists of an image of a wave where the top half is yellow in color and the bottom half is plum in color.
Color Claim
The color(s) yellow and plum is/are claimed as a feature of the mark.
Pseudo Mark
C

Classification

International Classes
005